With $35 Million in Funding, Waltz Health Aims to Lower Drug Prices Working With – Not Against – The System

Published On: April 26, 2022

After a 30-year career as an executive at some of the country’s largest pharmacy benefit managers – the middlemen that help set drug prices between manufacturers and insurers – Mark Thierer is ready for his next act: helping customers find the lowest prices.

Continue reading here on Forbes. 

Subscribe To Our Newsletter

Get the latest cancer policy news and updates from COPA direct to your inbox.

We respect your policy and will never share your e-mail address.